(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of 5.99% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.02%.
Nephros's revenue in 2025 is $17,930,000.On average, 4 Wall Street analysts forecast NEPH's revenue for 2025 to be $187,178,394, with the lowest NEPH revenue forecast at $178,039,447, and the highest NEPH revenue forecast at $194,617,072. On average, 3 Wall Street analysts forecast NEPH's revenue for 2026 to be $206,200,157, with the lowest NEPH revenue forecast at $198,123,878, and the highest NEPH revenue forecast at $212,267,993.
In 2027, NEPH is forecast to generate $247,814,248 in revenue, with the lowest revenue forecast at $238,101,459 and the highest revenue forecast at $255,104,152.